PABPN1 gene therapy for oculopharyngeal muscular dystrophy

Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant, late-onset muscle disorder characterized by ptosis, swallowing difficulties, proximal limb weakness and nuclear aggregates in skeletal muscles. OPMD is caused by a trinucleotide repeat expansion in the PABPN1 gene that results in an...

Descripción completa

Detalles Bibliográficos
Autores principales: Malerba, A., Klein, P., Bachtarzi, H., Jarmin, S. A., Cordova, G., Ferry, A., Strings, V., Espinoza, M. Polay, Mamchaoui, K., Blumen, S. C., St Guily, J. Lacau, Mouly, V., Graham, M., Butler-Browne, G., Suhy, D. A., Trollet, C., Dickson, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380963/
https://www.ncbi.nlm.nih.gov/pubmed/28361972
http://dx.doi.org/10.1038/ncomms14848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380963/
https://www.ncbi.nlm.nih.gov/pubmed/28361972
http://dx.doi.org/10.1038/ncomms14848

Ejemplares similares